Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01989923 · ClinicalTrials.gov registry record · NA
Smoking Cessation in Women With Gynecological Conditions
A NA study of Cervical Dysplasia, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT01989923 is a NA study of Cervical Dysplasia that has completed, run by University of Oklahoma. The registered enrollment target is 31 participants, below the 545-participant average among 7 other Cervical Dysplasia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01989923, a NA study of Cervical Dysplasia, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
This feasibility study will compare two smoking cessation methods, traditional nicotine replacement therapy and Electronic Nicotine Delivery Systems (electronic cigarettes) in patients with gynecological conditions.
Conditions Studied
Interventions
- OTHER Nicotine Replacement Therapy
- DEVICE Electronic Cigarettes
Study Locations (1)
Oklahoma
- Stephenson Cancer Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01989923
The ClinicalTrials.gov registry entry for NCT01989923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 545-participant average among 7 other Cervical Dysplasia trials with a reported enrollment target (94% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Nicotine Replacement Therapy is the first listed.
NCT01989923 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01989923 about?
NCT01989923 is a clinical study titled "Smoking Cessation in Women With Gynecological Conditions". This feasibility study will compare two smoking cessation methods, traditional nicotine replacement therapy and Electronic Nicotine Delivery Systems (electronic cigarettes) in patients with gynecological conditions.
What is the current status of trial NCT01989923?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2013-06. Estimated completion is 2017-04-13.
What conditions does trial NCT01989923 study?
This clinical trial studies the following conditions: Cervical Dysplasia.
What interventions are being tested in trial NCT01989923?
The interventions under investigation include: Nicotine Replacement Therapy (OTHER), Electronic Cigarettes (DEVICE).
Who is sponsoring clinical trial NCT01989923?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01989923 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
RECRUITING · NA
-
Coherence Imaging of the Cervical Epithelium With Scanning a/LCI
COMPLETED · NA
-
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RECRUITING
-
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
RECRUITING · Phase 2
-
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
COMPLETED · Phase 3
-
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.